300142 沃森生物
按盤價 
14.510 +0.300 (+2.111%)
14.510 +0.300 (+2.111%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.707 | 4.550 | 8.295 | 5.692 | 17.584 |
| 總資產報酬率 ROA (%) | 1.676 | 2.712 | 5.023 | 3.670 | 12.046 |
| 投入資產回報率 ROIC (%) | 2.460 | 4.178 | 7.803 | 5.471 | 17.278 | 邊際利潤分析 |
| 銷售毛利率 (%) | 79.423 | 85.474 | 88.018 | 88.612 | 86.397 |
| 營業利潤率 (%) | 13.360 | 14.925 | 21.615 | 20.511 | 46.828 |
| 息稅前利潤/營業總收入 (%) | 16.052 | 12.835 | 19.807 | 19.355 | 45.682 |
| 淨利潤/營業總收入 (%) | 16.375 | 12.430 | 18.446 | 17.366 | 41.211 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 103.083 | 160.534 | 119.595 | 117.808 | 74.735 |
| 價值變動淨收益/利潤總額(%) | -23.755 | -38.004 | -17.519 | -31.436 | 20.774 |
| 營業外收支淨額/利潤總額(%) | 23.464 | -2.503 | -2.707 | -0.188 | -0.217 | 償債能力分析 |
| 流動比率 (X) | 3.095 | 2.726 | 2.550 | 2.374 | 3.362 |
| 速動比率 (X) | 2.715 | 2.403 | 2.266 | 2.104 | 3.022 |
| 資產負債率 (%) | 21.819 | 26.901 | 28.340 | 26.878 | 0.186 |
| 帶息債務/全部投入資本 (%) | 4.646 | 4.120 | 1.426 | 0.063 | -3.079 |
| 股東權益/帶息債務 (%) | 1,963.383 | 2,196.571 | 6,535.940 | 151,499.450 | -3,169.446 |
| 股東權益/負債合計 (%) | 292.930 | 222.946 | 209.008 | 230.844 | 365.545 |
| 利息保障倍數 (X) | -11.439 | -7.437 | -15.997 | -17.309 | -43.736 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 366.650 | 292.173 | 214.357 | 233.085 | 154.118 |
| 存貨周轉天數 (天) | 595.382 | 611.627 | 552.109 | 619.485 | 358.645 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 04/11/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
